findmyKOL

Paul Thuluvath, MD

Enriched profile

Medical Director, The Melissa L. Posner Institute for Digestive Health & Liver Disease; Chief, Division of Gastroenterology · Mercy Medical Center

ORCIDNPI
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyGastroenterologyFocusLiver Disease and Transplantation+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNone verifiedPayments2021–2025NIH funding1999–1999

Paul Thuluvath is Medical Director, The Melissa L. Posner Institute for Digestive Health & Liver Disease; Chief, Division of Gastroenterology at Mercy Medical Center. OpenAlex indexes 496 publications with 25,181 citations (h-index 85); ClinicalTrials.gov lists 7 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Gastroenterology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Paul J. Thuluvath, MD, is Medical Director, The Melissa L. Posner Institute for Digestive Health & Liver Disease at Mercy Medical Center, Baltimore, MD. The public record shows 496 publications with 25,181 citations (h-index 85), centered on Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Organ Transplantation Techniques and Outcomes. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 44 companies, 1 NIH-funded awards (1999–1999).

  • Most recent indexed publication: 2024 · Liver international
  • Top research focus: Liver Disease and Transplantation
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 44 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Varicose Veins2 trialsEsophageal and Gastric Varices2 trialsViral Hepatitis (B/C)1 trialHypertension1 trialHemorrhage1 trialHypertension, Portal1 trialHepatitis B1 trialCholangitis, Sclerosing1 trialCholangitis1 trialNASH / NAFLD / MASH1 trialNon-alcoholic Fatty Liver Disease1 trialFatty Liver1 trialFatty Liver, Alcoholic1 trialHepatitis, Alcoholic1 trial

Research focus

OpenAlex concept fingerprint
Liver Disease and TransplantationLiver Disease Diagnosis and TreatmentOrgan Transplantation Techniques and OutcomesHepatitis C virus researchLiver Diseases and Immunity

Drugs & molecules

across trials, industry payments and publications
Livdelzigeneric · SeladelparClinical trialsIndustry payments21Publications1Mavyretgeneric · Glecaprevir / pibrentasvirClinical trialsIndustry payments50PublicationsEpclusageneric · Sofosbuvir / velpatasvirClinical trialsIndustry payments47Publications

Works with

trial sponsors and companies reporting payments
Gilead Sciences, Inc.Clinical trialsIndustry payments134Abbvie Inc.Clinical trialsIndustry payments69Madrigal PharmaceuticalsClinical trialsIndustry payments43

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
496publications

Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.

25,181citations

Total citations across indexed works.

85h-index

Hirsch index (OpenAlex). i10-index 253.

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials
44companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 1999–1999

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

44 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    54.2%
    Bile Acid11.3%
    Ursodiol100%
    Part D26 patients
    Proton pump inhibitor10.5%
    Omeprazole70%Pantoprazole Sodium30%
    Part D<11 patients
  • Cancer & immunology

    25.8%
    Calcineurin inhibitor14.1%
    Tacrolimus100%
    Part D29 patients
    Purine Antimetabolite9.1%
    Azathioprine100%
    Part D16 patients
  • Cardiovascular

    12.8%
    Calcium channel blocker4%
    Amlodipine Besylate100%
    Part D11 patients
    Loop diuretic3%
    Furosemide100%
    Part D11 patients
1 more therapeutic area behind the reveal.Reveal →
Where care is delivered (Part B)59.6% facility · 40.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

1 NIH research award on record, funded 19991999 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

1 congress contribution (2019) across ASCO per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Leroy R. Thacker64K. Rajender Reddy60Jasmohan S. Bajaj60

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Facebook

    facebook.com/MercyMedicalCenter/videos/medoscopy-with-mercys-dr-anurag-maheshwari-and-dr-paul-thuluvath-part-1/1832172477355825

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com
  • ResearchGate

    researchgate.net/scientific-contributions/Paul-J-Thuluvath-38300208

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdmercy.com
  • Editorial Board member

    Liver Transplantation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdmercy.com
  • Editorial Board member

    Gastrointestinal Endoscopy

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mdmercy.com

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
3 more media items behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.